Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

▤ Summary

Candel Therapeutics granted inducement stock options to two new employees under its 2025 Inducement Plan. The awards cover 31,400 shares of common stock at an exercise price of $13.07 per share. The options vest partly on the first anniversary of each employee’s start date and then monthly over three years. The company says the grants were approved to attract the employees into employment and comply with Nasdaq Listing Rule 5635(c)(4).

▦ Linked Companies